Business and other management consultancy activities
PHARMAPATENT AS
Revenue 2025
NOK 174,000
Operating profit
NOK 19,000
Equity
NOK 2.6m
Incorporated
2008
Share capital
NOK 100,000
Roles
Regnskapsfører
Styrets lederJohn Sigurd Mjøen Svendsen
VaramedlemWenche Gunvor Berg Stensen
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| JOHN SIGURD MJØEN SVENDSEN | 50.0% | 500.000000 | 2025 |
| WENCHE GUNVOR BERG STENSEN | 50.0% | 500.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| PHARMASUM THERAPEUTICS AS | Active | 8.0% | 258340.000000 |
| AMICOAT AS | Active | 0.9% | 521700.000000 |
| LYTIX BIOPHARMA ASA | Active | 0.2% | 152420.000000 |
| PROPHYLIX PHARMA HOLDING AS | Active | 0.1% | 666.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.